<qa>  What type of therapy did patients with advanced renal cell carcinoma receive?- Patients with advanced renal cell carcinoma treated with Sorafenib Nexavar as second-line therapy after Sunitinib Sutent or Bevacizumab Avastin for first-line therapy about 100 patients 